Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 5
1973 4
1975 3
1976 1
1977 4
1978 3
1979 3
1980 1
1981 4
1982 1
1983 3
1984 2
1985 5
1986 3
1987 6
1988 5
1989 3
1990 7
1991 5
1992 6
1993 6
1994 11
1995 7
1996 6
1997 6
1998 7
1999 4
2000 5
2001 4
2002 6
2003 7
2004 3
2005 5
2006 9
2007 7
2008 3
2009 3
2010 6
2011 5
2012 4
2013 9
2014 9
2015 5
2016 2
2017 3
2018 1
2019 1
2020 1
2021 3
2022 2
2023 1
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):837-53. Lancet. 1998. PMID: 9742976 Clinical Trial.
METHODS: 3867 newly diagnosed patients with type 2 diabetes, median age 54 years (IQR 48-60 years), who after 3 months' diet treatment had a mean of two fasting plasma glucose (FPG) concentrations of 6.1-15.0 mmol/L were randomly assigned intensive policy with a sulphonylurea (ch …
METHODS: 3867 newly diagnosed patients with type 2 diabetes, median age 54 years (IQR 48-60 years), who after 3 months' diet treatment had a …
Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Lebovitz HE. Lebovitz HE. Pharmacotherapy. 1985 Mar-Apr;5(2):63-77. doi: 10.1002/j.1875-9114.1985.tb03405.x. Pharmacotherapy. 1985. PMID: 3923454 Review.
Glipizide is a second-generation sulfonylurea in which the substitutions on the arylsulfonylurea nucleus are large, relatively nonpolar groups. ...The most important component of the antidiabetic action of glipizide is its effect in potentiating insulin action. G …
Glipizide is a second-generation sulfonylurea in which the substitutions on the arylsulfonylurea nucleus are large, relatively nonpol …
Glipizide: an overview.
Shuman CR. Shuman CR. Am J Med. 1983 Nov 30;75(5B):55-9. doi: 10.1016/0002-9343(83)90254-1. Am J Med. 1983. PMID: 6369968 Clinical Trial.
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitus. The data demonstrate that this agent, one of the newest oral hypoglycemics, is an effective and safe compound with unique properties. ...
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitu …
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study.
Abdul-Ghani M, Puckett C, Abdelgani S, Merovci A, Lavrynenko O, Adams J, Triplitt C, DeFronzo RA. Abdul-Ghani M, et al. BMJ Open Diabetes Res Care. 2025 Apr 27;13(2):e004981. doi: 10.1136/bmjdrc-2025-004981. BMJ Open Diabetes Res Care. 2025. PMID: 40288809 Free PMC article. Clinical Trial.
INTRODUCTION: To compare carotid intima-media thickness (cIMT) and liver fat content in subjects who maintained good glycemic control for 6 years on initial triple therapy with metformin/exenatide/pioglitazone versus sequential add-on therapy with metformin followed with glipi …
INTRODUCTION: To compare carotid intima-media thickness (cIMT) and liver fat content in subjects who maintained good glycemic control for 6 …
Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial.
Peng X, Chen S, Zhong L, Li Y, Wu C, Zhong L, Chen W, Yang J, Zeng J, Tang S. Peng X, et al. Front Endocrinol (Lausanne). 2023 May 24;14:1176256. doi: 10.3389/fendo.2023.1176256. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37293505 Free PMC article. Clinical Trial.
RESULTS: At the end of intervention, CP, like Glipizide, significantly improved HbA1c level and other glucose metabolism parameters (fasting plasma glucose (FBG), 2-hour post-meal blood glucose (2hPBG), the area under curve of oral glucose tolerance test glucose (OGTT gluc …
RESULTS: At the end of intervention, CP, like Glipizide, significantly improved HbA1c level and other glucose metabolism parameters ( …
Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.
Cersosimo E, YueJuan Q, Baskoy G, Chavez A, Barkhordarian M, Hansis-Diarte A, Triplitt C, DeFronzo RA. Cersosimo E, et al. Diabetes Obes Metab. 2025 Feb;27(2):944-952. doi: 10.1111/dom.16094. Epub 2024 Nov 27. Diabetes Obes Metab. 2025. PMID: 39604709 Clinical Trial.
MATERIALS AND METHODS: Sixty T2D patients with elevated [HYPER] and normal [NORMO] GFR were randomized to dapagliflozin 10 mg/day [DAPA/HYPER, n = 15; DAPA/NORMO, n = 15] or to metformin/glipizide [CONTROL/HYPER, n = 15; CONTROL/NORMO, n = 15] to reach similar glycaemic co …
MATERIALS AND METHODS: Sixty T2D patients with elevated [HYPER] and normal [NORMO] GFR were randomized to dapagliflozin 10 mg/day [DAPA/HYPE …
Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
Feig DS, Briggs GG, Koren G. Feig DS, et al. Ann Pharmacother. 2007 Jul;41(7):1174-80. doi: 10.1345/aph.1K045. Epub 2007 May 29. Ann Pharmacother. 2007. PMID: 17535842 Review.
DATA SYNTHESIS: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metformin and rosiglitazone cross readily. ...The human information is inadequate to evaluate the risk of glipizide or the thiazolidinedio …
DATA SYNTHESIS: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metfo …
Saxagliptin versus glipizide as add-on therapy to metformin: assessment of hypoglycemia.
Mintz ML, Minervini G. Mintz ML, et al. Curr Med Res Opin. 2014 May;30(5):761-70. doi: 10.1185/03007995.2014.880674. Epub 2014 Jan 30. Curr Med Res Opin. 2014. PMID: 24397584 Clinical Trial.
RESULTS: Of 858 patients randomized, 428 received saxagliptin + metformin, and 430 received glipizide + metformin. Saxagliptin was noninferior to glipizide in lowering HbA1c. Hypoglycemia with saxagliptin + metformin and glipizide + metformin was reported by …
RESULTS: Of 858 patients randomized, 428 received saxagliptin + metformin, and 430 received glipizide + metformin. Saxagliptin was no …
Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.
Kradjan WA, Takeuchi KY, Opheim KE, Wood FC Jr. Kradjan WA, et al. Pharmacotherapy. 1995 Jul-Aug;15(4):465-71. Pharmacotherapy. 1995. PMID: 7479199 Clinical Trial.
STUDY OBJECTIVE: To determine the pharmacokinetics and pharmacodynamics of glipizide given as a single, oral, 20-mg dose, versus three different divided-dose regimens totaling 20 mg each. ...The divided-dose regimens were designed to simulate delayed absorption of the drug …
STUDY OBJECTIVE: To determine the pharmacokinetics and pharmacodynamics of glipizide given as a single, oral, 20-mg dose, versus thre …
A clinical trial with glipizide - a relative new sulphonylurea.
Singarayar J, Sunderam S. Singarayar J, et al. Med J Zambia. 1978 Aug-Sep;12(4):97. Med J Zambia. 1978. PMID: 398642 Clinical Trial.
Glipizide is a relatively new sulphonylurea- antidiabetic agent. 24 maturity-onset diabetics were studied to determine the dosage required to produce adequate control and the safety and tolerance of the drug. It was concluded that glipizide is a safe and potent anti …
Glipizide is a relatively new sulphonylurea- antidiabetic agent. 24 maturity-onset diabetics were studied to determine the dosage req …
215 results